Executive Director/PDMR Share Purchases

Aterian PLC
24 September 2024
 

ATERIAN Plc

 





 

("Aterian ", the "Company" or the "Group")

 

 



Executive Director/PDMR Share Purchases

 



Aterian Plc (LSE: ATN), the exploration and development company advancing its portfolio of African-focused critical and strategic metal assets was informed on 24 September 2024 following the publication of the half-year report and completion of the close period of the following purchases of the Company's ordinary shares by the Executive Chairperson and PDMRs of the Company.

 

 

The purchases made on 24 September 2024 are detailed below:

 

 

 

1.       

Details of the person discharging managerial responsibilities / person closely associated

 

 

a)

Name

Charles Bray

 

 

2.       

Reason for the notification

 

 

a)

Position/status

PDMR, Director

 

 

b)

Initial notification / Amendment

Initial

 

 

3.       

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

Name

Aterian plc

 

 

b)

LEI

2138005GAARIE1JMP262

 

 

4.       

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

Description of the financial instrument, type of instrument

Ordinary Shares

 

 

Identification code

ISIN: GB00BPJMN573

 

 

b)

Nature of the transaction

Purchase of shares

 

 

c)

Price(s) and volume(s)

Price (s)

Volume (s)

£0.50

£0.5143

29,000

35,000 

 

 

d)

Aggregate information


 

 

- Aggregate volume

64,000 shares in aggregate

 

 

- Total Price

£32,500

 

 

e)

Date of the transaction

24/09/2024

 

 

f)

Place of the transaction

London Stock Exchange

 

 

g)

Additional information

NA

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Aterian (ATN)
UK 100

Latest directors dealings